PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.60%
Negative revenue growth while VALMT.HE stands at 28.50%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.22%
Negative gross profit growth while VALMT.HE is at 39.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-5.65%
Negative EBIT growth while VALMT.HE is at 112.50%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.65%
Negative operating income growth while VALMT.HE is at 112.50%. Joel Greenblatt would press for urgent turnaround measures.
-12.70%
Negative net income growth while VALMT.HE stands at 111.43%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-12.50%
Negative EPS growth while VALMT.HE is at 113.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-12.50%
Negative diluted EPS growth while VALMT.HE is at 113.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.22%
Share reduction while VALMT.HE is at 1.21%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.22%
Reduced diluted shares while VALMT.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-43.60%
Negative OCF growth while VALMT.HE is at 20.17%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-107.83%
Negative FCF growth while VALMT.HE is at 23.47%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.25%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 5.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.04%
Negative 5Y CAGR while VALMT.HE stands at 46.43%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-7.42%
Negative 3Y CAGR while VALMT.HE stands at 15.16%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-34.52%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 275.84%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-7.51%
Negative 5Y OCF/share CAGR while VALMT.HE is at 473.89%. Joel Greenblatt would question the firm’s operational model or cost structure.
-56.90%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 123.81%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
165.20%
Below 50% of VALMT.HE's 1128.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
62.06%
Below 50% of VALMT.HE's 218.59%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
76.98%
Below 50% of VALMT.HE's 174.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
27.54%
Below 50% of VALMT.HE's 126.02%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
56.33%
5Y equity/share CAGR above 1.5x VALMT.HE's 16.08%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.12%
3Y equity/share CAGR above 1.5x VALMT.HE's 10.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.06%
Firm’s AR is declining while VALMT.HE shows 3.85%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.98%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.52%
Asset growth at 50-75% of VALMT.HE's 4.18%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.16%
50-75% of VALMT.HE's 6.91%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-5.35%
We’re deleveraging while VALMT.HE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.04%
SG&A declining or stable vs. VALMT.HE's 23.73%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.